CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Synple is developing an automated capsule-based machine for drug discovery that simplifies the synthesis of new molecules. This technology aims to enhance productivity and safety in chemical research by minimizing user exposure to hazardous substances while streamlining the synthesis process.
Drug discovery continues to rely on the synthesis of tiny amounts of candidate molecules using unpredictable protocols that require highly trained specialists.
As such, it remains expensive, time-consuming, unsafe, and environmentally unfriendly.
Declining productivity, high costs, and safety issues, have driven a large amount of chemical synthesis to lower cost countries, which introduces delays and uncertainty in the drug discovery process, where the flexibility to rapidly prepare new molecule…
SYNPLE CHEM AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
